Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer

Oncogene

Volumn 30, Issue 28, 2011, Pages 3139-3152

  Sreekanth, C N ^a   Bava, S V ^a   Sreekumar, E ^a   Anto, R J ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

apoptosis; chemical carcinogenesis; chemosensitization; natural products; survival factors; xenograft tumors

Indexed keywords

3 METHYLCHOLANTHRENE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PROTEIN KINASE B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SURVIVAL; TUMOR VOLUME; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL MEMBRANE; CELL PROLIFERATION; CURCUMIN; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOWN-REGULATION; DRUG SYNERGISM; ENZYME ACTIVATION; FEMALE; HELA CELLS; HUMANS; LIPOSOMES; MAP KINASE SIGNALING SYSTEM; METHYLCHOLANTHRENE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PACLITAXEL; POLY ADENOSINE DIPHOSPHATE RIBOSE; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; MUS;

EID: 79960382286     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.23     Document Type: Article

References (65)

1. Aggarwal BB. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
2. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE et al. (2005). Curcumin suppresses the paclitaxelinduced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498. (Pubitemid 41507710)
3. Aggarwal BB, Surh YJ, Shishodia S. (2007). The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. Springer: New York.
4. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69: 195-206. (Pubitemid 43048906)
5. Ahn KS, Sethi G, Aggarwal BB. (2007). Nuclear factor-kappa B: from clone to clinic. Curr Mol Med 7: 619-637. (Pubitemid 350201663)
6. Ahn KS, Sethi G, Aggarwal BB. (2008). Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. Biochem Pharmacol 75: 907-913. (Pubitemid 351174113)
7. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. (2007). Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818.
8. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. (2002). Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23: 143-150. (Pubitemid 34213563)
9. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. (2002). Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64: 573-582.
10. Banerjee S, Bueso-Ramos C, Aggarwal BB. (2002). Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62: 4945-4954. (Pubitemid 34984418)
11. Bava SV, Puliappadamba VT, Deepti A, Nair A, Karunagaran D, Anto RJ. (2005). Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J Biol Chem 280: 6301-6308. (Pubitemid 40341176)
12. Bava SV, Sreekanth CN, Thulasidasan AK, Anto NP, Cheriyan VT, Puliyappadamba VT et al. (2010). Akt is upstream and MAPKs are downstream of NF-kappaB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. Int J Biochem Cell Biol (doi:10.1016/j.biocel.2010.09.011).
13. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N et al. (2003). NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22: 90-97. (Pubitemid 36152887)
14. Blagosklonny MV, Fojo T. (1999). Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83: 151-156. (Pubitemid 29449089)
15. Bradley G, Ling V. (1994). P-glycoprotein, multidrug resistance and tumor progression. Cancer Metastasis Rev 13: 223-233. (Pubitemid 24220007)
16. Brake T, Lambert PF. (2005). Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 102: 2490-2495. (Pubitemid 40279404)
17. Cantley LC. (2002). The phosphoinositide 3-kinase pathway. Science 296: 1655-1657. (Pubitemid 34579158)
18. Chang L, Karin M. (2001). Mammalian MAP kinase signalling cascades. Nature 410: 37-40. (Pubitemid 32225829)
19. Chang YF, Li LL, Wu CW, Liu TY, Lui WY, PEng FK et al. (1996). Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77: 14-18. (Pubitemid 26002731)
20. Chaturvedi MM, Mukhopadhyay A, Aggarwal BB. (2000). Assay for redox-sensitive transcription factor. Methods Enzymol 319: 585-602. (Pubitemid 30448077)
21. Chhabra SK, Kaur S, Rao AR. (1995). Modulatory influence of the oral contraceptive pill, Ovral, on 3-methylcholanthrene-induced carcinogenesis in the uterus of mouse. Oncology 52: 32-34.
22. Choi BH, Kim CG, Lim Y, Shin SY, Lee YH. (2008). Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett 259: 111-118. (Pubitemid 350235095)
23. Freshney RI, Freshney MG. (2002). Culture of Epithelial Cells, 2nd edn. Wiley-Liss: New York.
24. Gagnon V, Van Themsche C, Turner S, Leblanc V, Asselin E. (2008). Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis 13: 259-271.
25. Ganta S, Amiji M. (2009). Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm 6: 928-939.
26. Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T et al. (1997). Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 272: 17118-17125. (Pubitemid 27289821)
27. Hokeness K, Qiu LH, Vezeridis M, Yan BF, Mehta S, Wan YS. (2005). IFN-gamma enhances paclitaxel-induced apoptosis that is modulated by activation of caspases 8 and 3 with a concomitant down regulation of the AKT survival pathway in cultured human keratinocytes. Oncol Rep 13: 965-969.
28. Hou XL, Takahashi K, Tanaka K, Tougou K, Qiu F, Komatsu K et al. (2008). Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm 358: 224-229.
29. Hussain SP, Rao AR. (1991). Chemopreventive action of mace (Myristica fragrans, Houtt) on methylcholanthrene-induced carcinogenesis in the uterine cervix in mice. Cancer Lett 56: 231-234.
30. Inoue M, Matsumoto S, Saito H, Tsujitani S, Ikeguchi M. (2008). Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer. Int J Cancer 123: 2696-2701.
31. Kane LP, Shapiro VS, Stokoe D, Weiss A. (1999). Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 9: 601-604.
32. Karin M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270: 16483-16486.
33. Karin M, Cao Y, Greten FR, Li ZW. (2002). NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2: 301-310. (Pubitemid 37328783)
34. Kim SH, Juhnn YS, Song YS. (2007). Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells. Ann NY Acad Sci 1095: 82-89.
35. Kunnumakkara AB, Anand P, Aggarwal BB. (2008). Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225.
36. Kuo HC, Lee HJ, Hu CC, Shun HI, Tseng TH. (2006). Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol Appl Pharmacol 210: 55-62.
37. Kuttan R, Bhanumathy P, Nirmala K, George MC. (1985). Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29: 197-202. (Pubitemid 16175818)
38. Kutuk O, Letai A. (2008). Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. Cancer Res 68: 7985-7994.
39. Lanni JS, Lowe SW, Licitra EJ, Liu JO, Jacks T. (1997). p53- independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci USA 94: 9679-9683. (Pubitemid 27408122)
40. Li L, Ahmed B, Mehta K, Kurzrock R. (2007). Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 6: 1276-1282. (Pubitemid 46711990)
41. Li L, Braiteh FS, Kurzrock R. (2005). Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104: 1322-1331. (Pubitemid 41282806)
42. Liu B, Fang M, Lu Y, Mills GB, Fan Z. (2001). Involvement of JNKmediated pathway in EGF-mediated protection against paclitaxelinduced apoptosis in SiHa human cervical cancer cells. Br J Cancer 85: 303-311. (Pubitemid 32695756)
43. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
44. Logan RM, Gibson RJ, Sonis ST, Keefe DM. (2007). Nuclear factorkappaB (NF-kappaB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43: 395-401. (Pubitemid 46420789)
45. Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y et al. (2002). Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel. J Biol Chem 277: 33490-33500. (Pubitemid 34984873)
46. Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM, Brem H. (2007). Paclitaxel: a review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf 6: 609-621. (Pubitemid 351308218)
47. Murphy ED. (1961). Carcinogenesis of the uterine cervix in mice: effect of diethylstilbestrol after limited application of 3-methylcholanthrene. J Natl Cancer Inst 27: 611-653.
48. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D. (2003). NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 22: 50-58. (Pubitemid 36152883)
49. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr. RJ, Sledge Jr. GW. (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639. (Pubitemid 27281838)
50. Narayanan NK, Nargi D, Randolph C, Narayanan BA. (2009). Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125: 1-8.
51. Prasad S, Ravindran J, Aggarwal BB. (2010). NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem 336: 25-37.
52. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M. (2008). Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76: 1340-1351.
53. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H et al. (2001). Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7: 4136-4142. (Pubitemid 34044638)
54. Saunders DE, Lawrence WD, Christensen C, Wappler NL, Ruan H, Deppe G. (1997). Paclitaxel-induced apoptosis in MCF-7 breastcancer cells. Int J Cancer 70: 214-220. (Pubitemid 27107420)
55. Singh S, Aggarwal BB. (1995). Activation of transcription factor NFkappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem 270: 24995-25000.
56. Sumitomo M, Tachibana M, Nakashima J, Murai M, Miyajima A, Kimura F et al. (1999). An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. J Urol 161: 674-679.
57. Sur I, Ulvmar M, Toftgard R. (2008). The two-faced NF-kappaB in the skin. Int Rev Immunol 27: 205-223.
58. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS et al. (2000). Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89: 2274-2281.
59. Tang X, Liu D, Shishodia S, Ozburn N, Behrens C, Lee JJ et al. (2006). Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer 107: 2637-2646. (Pubitemid 44845619)
60. Thevenod F, Friedmann JM, Katsen AD, Hauser IA. (2000). Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J Biol Chem 275: 1887-1896. (Pubitemid 30060813)
61. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
62. Yagi H, Yotsumoto F, Sonoda K, Kuroki M, Mekada E, Miyamoto S. (2009). Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. Int J Cancer 124: 1429-1439.
63. Yusuf RZ, Duan Z, Lamendola DE, Penson RT, Seiden MV. (2003). Paclitaxel resistance: molecular mechanisms and pharmacologic manipulation. Curr Cancer Drug Targets 3: 1-19. (Pubitemid 36119417)
64. Zhang Z, Ma J, Li N, Sun N, Wang C. (2006). Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. Ann Thorac Surg 82: 243-248.
65. Zhou G, Kuo MT. (1997). NF-kappaB-mediated induction of mdr1b expression by insulin in rat hepatoma cells. J Biol Chem 272: 15174-15183. (Pubitemid 27255533)